Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)
Turkey · Delayed Price · Currency is TRY 32.40
+0.32 (1.00%)
At close: Jul 18, 2025, 6:00 PM GMT+3
IST:MEDTR Cash Flow Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -11.21 | 73.43 | 37.35 | 114.34 | 167.7 | 60.43 |
Depreciation & Amortization | 101.48 | 88.31 | 75.63 | 49.83 | 11.87 | 12.02 |
Loss (Gain) From Sale of Assets | 4.92 | 2.24 | -127.37 | -10.94 | -1.25 | -1.28 |
Asset Writedown & Restructuring Costs | -1.52 | -1.52 | -13.44 | -3.24 | -4.22 | 1.91 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.03 |
Loss (Gain) on Equity Investments | -11.46 | -12.35 | -10.49 | -4.53 | 0.5 | 0.89 |
Stock-Based Compensation | - | - | - | -0.31 | - | - |
Provision & Write-off of Bad Debts | 1.13 | 1.13 | - | - | -0.1 | 0.1 |
Other Operating Activities | -30.43 | 20.15 | 18.63 | 178.69 | 24.61 | 2.56 |
Change in Accounts Receivable | 140.61 | 81.56 | -6.3 | -39.56 | -34.57 | -5.63 |
Change in Inventory | 211.79 | -30.45 | 91.21 | -91.34 | -17.09 | -11.85 |
Change in Accounts Payable | -97.09 | 14.17 | 20.93 | 53.93 | 24.27 | 24.91 |
Change in Unearned Revenue | -2.38 | -4.89 | -12.49 | 0.67 | 5.09 | 1.04 |
Change in Other Net Operating Assets | 382.38 | 364.66 | 727.36 | -200.38 | -140.18 | -11.8 |
Operating Cash Flow | 688.23 | 596.44 | 801.02 | 47.16 | 36.64 | 73.26 |
Operating Cash Flow Growth | 27.62% | -25.54% | 1598.51% | 28.70% | -49.98% | - |
Capital Expenditures | -184.85 | -191.72 | -299.56 | -90.82 | -8.92 | -20.85 |
Sale of Property, Plant & Equipment | 2.98 | 7.76 | 322.5 | 11.38 | 2.9 | 3.74 |
Sale (Purchase) of Intangibles | -9.84 | -9.61 | -0.14 | -1.14 | -0.31 | -0.59 |
Investment in Securities | - | - | - | - | - | 0.04 |
Other Investing Activities | 345.99 | 353.17 | 94.6 | - | - | -0 |
Investing Cash Flow | 154.27 | 159.6 | 117.4 | -80.57 | -6.33 | -22.55 |
Long-Term Debt Issued | - | - | 42.5 | 45 | - | 27.53 |
Long-Term Debt Repaid | - | -116.28 | -62.37 | -24.76 | -13.42 | -25.42 |
Net Debt Issued (Repaid) | -118.23 | -116.28 | -19.88 | 20.24 | -13.42 | 2.12 |
Issuance of Common Stock | 125.18 | 125.18 | - | - | 184.22 | - |
Repurchase of Common Stock | - | - | -134.02 | - | - | - |
Common Dividends Paid | -34.61 | -34.61 | -150 | -140 | - | - |
Other Financing Activities | -162.05 | -205.4 | -217.55 | -10.34 | 3.72 | -3.15 |
Financing Cash Flow | -189.71 | -231.1 | -521.45 | -130.11 | 174.51 | -1.03 |
Foreign Exchange Rate Adjustments | 67.04 | - | - | -382.61 | - | - |
Miscellaneous Cash Flow Adjustments | -526.68 | -439.23 | -412.96 | - | -0 | - |
Net Cash Flow | 193.16 | 85.7 | -16 | -546.13 | 204.82 | 49.68 |
Free Cash Flow | 503.38 | 404.72 | 501.46 | -43.66 | 27.72 | 52.41 |
Free Cash Flow Growth | 120.99% | -19.29% | - | - | -47.11% | - |
Free Cash Flow Margin | 24.05% | 19.32% | 23.92% | -2.74% | 7.38% | 14.59% |
Free Cash Flow Per Share | 4.23 | 3.40 | 4.21 | -0.37 | 0.23 | 0.56 |
Cash Interest Paid | 25.64 | 30.46 | 34.82 | 17.07 | 2.28 | 3.65 |
Cash Income Tax Paid | 35.84 | - | - | 93.56 | -21.99 | 4.13 |
Levered Free Cash Flow | -255.54 | -106.23 | -238.81 | -96.02 | 46.15 | - |
Unlevered Free Cash Flow | -213.41 | -60.13 | -191.25 | -71.22 | 54.5 | - |
Change in Net Working Capital | 214.73 | 92.44 | 203.78 | 270.26 | 3.82 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.